News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
28,524 Results
Type
Article (2518)
Company Profile (5)
Press Release (26001)
Section
Business (8788)
Career Advice (152)
Deals (1353)
Drug Delivery (21)
Drug Development (2562)
Employer Resources (19)
FDA (466)
Job Trends (1034)
News (14008)
Policy (2447)
Tag
2024 Bio NC Digital (1)
2025 Lone Star Bio Digital (1)
Academia (202)
Allergies (7)
Alliances (2514)
ALS (2)
Alzheimer's disease (64)
Antibody-drug conjugate (ADC) (8)
Approvals (466)
Artificial intelligence (13)
Automation (2)
Bankruptcy (4)
Best Places to Work (702)
BIOSECURE Act (16)
Biosimilars (10)
Biotechnology (1)
Brain cancer (1)
Breast cancer (12)
Cancer (80)
Cardiovascular disease (3)
Career advice (136)
Career pathing (2)
CAR-T (11)
Cell therapy (34)
Cervical cancer (2)
Clinical research (1807)
Collaboration (48)
Compensation (8)
COVID-19 (294)
CRISPR (1)
C-suite (6)
Cystic fibrosis (4)
Data (69)
Depression (2)
Diabetes (11)
Diagnostics (265)
Digital health (1)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (6)
Drug pricing (16)
Drug shortages (4)
Duchenne muscular dystrophy (2)
Earnings (2121)
Editorial (4)
Employer branding (2)
Employer resources (15)
Events (3469)
Executive appointments (19)
FDA (506)
Featured Employer (1)
Funding (29)
Gene editing (4)
Generative AI (3)
Gene therapy (14)
GLP-1 (46)
Government (777)
Grass and pollen (3)
Healthcare (1434)
IgA nephropathy (1)
Immunology and inflammation (7)
Indications (2)
Infectious disease (298)
Inflammatory bowel disease (8)
Inflation Reduction Act (3)
Influenza (2)
Intellectual property (6)
Interviews (27)
IPO (549)
IRA (11)
Job creations (355)
Job search strategy (124)
Labor market (4)
Layoffs (22)
Legal (498)
Liver cancer (2)
Lung cancer (15)
Lymphoma (3)
Management (4)
Manufacturing (52)
Medical device (521)
Medtech (521)
Mergers & acquisitions (827)
Metabolic disorders (24)
Multiple sclerosis (1)
Neurodegenerative disease (1)
Neuroscience (80)
NextGen: Class of 2025 (572)
Non-profit (567)
Northern California (66)
Obesity (12)
Opinion (32)
Ovarian cancer (1)
Pain (4)
Pancreatic cancer (1)
Parkinson's disease (6)
Partnered (3)
Patents (6)
Patient recruitment (5)
Peanut (3)
People (2463)
Pharmaceutical (2)
Pharmacy benefit managers (7)
Phase I (687)
Phase II (770)
Phase III (616)
Pipeline (51)
Podcasts (4)
Policy (38)
Postmarket research (52)
Preclinical (303)
Press Release (7)
Prostate cancer (1)
Radiopharmaceuticals (17)
Rare diseases (10)
Real estate (1078)
Recruiting (10)
Regulatory (1299)
Reports (3)
Research institute (150)
Resumes & cover letters (14)
RSV (3)
Schizophrenia (3)
Series A (8)
Series B (2)
Service/supplier (2)
Southern California (99)
Special edition (2)
Sponsored (6)
Startups (174)
Supply chain (6)
The Weekly (4)
United States (730)
Vaccines (57)
Venture capitalists (4)
Weight loss (11)
Women's health (3)
Date
Today (7)
Last 7 days (37)
Last 30 days (109)
Last 365 days (1493)
2025 (201)
2024 (1553)
2023 (1816)
2022 (2275)
2021 (2636)
2020 (2720)
2019 (3079)
2018 (2332)
2017 (1237)
2016 (1353)
2015 (1453)
2014 (985)
2013 (869)
2012 (944)
2011 (892)
2010 (750)
Location
Africa (61)
Alabama (4)
Alaska (1)
Arizona (4)
Arkansas (2)
Asia (2413)
Australia (230)
California (187)
Canada (67)
China (73)
Colorado (6)
Connecticut (5)
Delaware (4)
Europe (4633)
Florida (22)
Georgia (21)
Idaho (5)
Illinois (22)
India (3)
Indiana (25)
Japan (19)
Kansas (3)
Kentucky (1)
Maine (2)
Maryland (29)
Massachusetts (135)
Michigan (6)
Minnesota (8)
Mississippi (1)
Missouri (2)
Montana (9)
Nevada (2)
New Jersey (79)
New Mexico (1)
New York (46)
North Carolina (36)
Northern California (66)
Ohio (13)
Oklahoma (1)
Oregon (2)
Pennsylvania (40)
Rhode Island (1)
South America (79)
Southern California (99)
Tennessee (4)
Texas (9)
Utah (3)
Virginia (4)
Washington D.C. (10)
Washington State (5)
West Virginia (2)
Wisconsin (4)
28,524 Results for "bethany house".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
U.S. FDA Approves Label Expansion for ALK’s ODACTRA® (House Dust Mite Allergen Tablet) for Sublingual Use as Immunotherapy to Now Include Children with House Dust Mite Allergy
February 28, 2025
·
10 min read
Press Releases
FDA approves ODACTRA® for the treatment of house dust mite allergy in young children
February 28, 2025
·
2 min read
Pharmacy benefit managers
House Oversight Chair Calls on PBM Execs to Correct Testimonies
The chair of the House Committee on Oversight and Accountability wants the CEOs of CVS Caremark, Express Scripts and Optum Rx to fix statements they made in a hearing last month that contradicted the committee’s and Federal Trade Commission’s findings.
August 29, 2024
·
2 min read
·
Tristan Manalac
Business
Bethany L. Sensenig Joins Supernus’ Board of Directors
Supernus Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, announced that Bethany L. Sensenig has joined the Supernus Board of Directors effective immediately.
August 21, 2023
·
5 min read
BIOSECURE Act
BIOSECURE Act Sails Through House Passage, Lines Up Senate Vote
The U.S. House of Representatives on Monday overwhelmingly passed the bipartisan bill, which targets WuXi AppTec, WuXi Biologics and other Chinese biotech companies as potential national security risks.
September 10, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Chimerix to Speak Today at The White House Cancer Moonshot Forum
January 14, 2025
·
3 min read
China
House Lawmakers Raise Alarm About US Biopharma Companies Working With Chinese Military on Trials
In a letter to FDA Commissioner Robert Califf, a House committee flagged several U.S. companies—including Eli Lilly and Pfizer—that have allegedly worked with the People’s Liberation Army on clinical trials in Xinjiang, raising ethical and intellectual property concerns.
August 21, 2024
·
2 min read
·
Tristan Manalac
Drug pricing
‘Big Three’ PBMs to Face House Oversight Accountability as Hawaii Court Delivers Legal Victory
As scrutiny of pharmacy benefit managers mounts, a House committee will hold a hearing on the alleged anticompetitive business practices of these middlemen.
July 17, 2024
·
2 min read
·
Tristan Manalac
Policy
House Speaker Plans to Vote, Pass BIOSECURE Act into Law This Year
House Speaker Mike Johnson (R-La.) on Monday said he intends to have a “significant package of China-related legislation” signed into law by the end of this year, including the BIOSECURE Act which intends to stop federal contracts with Chinese “companies of concern.”
July 9, 2024
·
2 min read
·
Tyler Patchen
Policy
BIOSECURE Act Left Out of Department of Defense Spending Bill by House Rules Committee
The BIOSECURE Act, which seeks to protect U.S. national security from Chinese biotech companies, will not be part of the House of Representatives vote on the 2025 fiscal year National Defense Authorization Act.
June 12, 2024
·
2 min read
·
Tristan Manalac
1 of 2,853
Next
